Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland B Walter

Showing results (21-30 of 283) with videos related to

Pageof 29
Sort By:
Blood Reviews|April 7, 2020
Selection of initial therapy for newly-diagnosed adult acute myeloid leukemia: Limitations of predictive modelsRoland B Walter, Elihu H Estey
Best Practice & Research. Clinical Haematology|June 18, 2019
Novel monoclonal antibody-based therapies for acute myeloid leukemiaLinde M Morsink, Roland B Walter
Current Hematologic Malignancy Reports|April 22, 2015
Update on antigen-specific immunotherapy of acute myeloid leukemiaSarah A Buckley, Roland B Walter
Hematology. American Society of Hematology. Education Program|December 4, 2020
Practice patterns and outcomes for adults with acute myeloid leukemia receiving care in community vs academic settingsAnna B Halpern, Roland B Walter
Leukemia|June 27, 2024
Measurable residual disease in haematological and solid cancersRoland B Walter, Robert Peter Gale
Cancers|December 8, 2020
Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)Utkarsh H Acharya, Roland B Walter
Oncotarget|December 20, 2018
CLAG-M with dose-escalated mitoxantrone for adults with acute myeloid leukemiaAnna B Halpern, Roland B Walter
Cells|February 25, 2025
Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaMargery Gang, Megan Othus, Roland B Walter
Blood|September 6, 2024
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in adults over 70 years oldRoland B Walter, Victoria Potter, Charles Craddock
Leukemia & Lymphoma|June 9, 2016
Incorporating measurable ('minimal') residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemiaKristen Pettit, Wendy Stock, Roland B Walter
Pageof 29

Showing results (21-30 of 283) with videos related to

Sort By:
Pageof 29
Blood Reviews|April 7, 2020
Selection of initial therapy for newly-diagnosed adult acute myeloid leukemia: Limitations of predictive modelsRoland B Walter, Elihu H Estey
Best Practice & Research. Clinical Haematology|June 18, 2019
Novel monoclonal antibody-based therapies for acute myeloid leukemiaLinde M Morsink, Roland B Walter
Current Hematologic Malignancy Reports|April 22, 2015
Update on antigen-specific immunotherapy of acute myeloid leukemiaSarah A Buckley, Roland B Walter
Hematology. American Society of Hematology. Education Program|December 4, 2020
Practice patterns and outcomes for adults with acute myeloid leukemia receiving care in community vs academic settingsAnna B Halpern, Roland B Walter
Leukemia|June 27, 2024
Measurable residual disease in haematological and solid cancersRoland B Walter, Robert Peter Gale
Cancers|December 8, 2020
Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)Utkarsh H Acharya, Roland B Walter
Oncotarget|December 20, 2018
CLAG-M with dose-escalated mitoxantrone for adults with acute myeloid leukemiaAnna B Halpern, Roland B Walter
Cells|February 25, 2025
Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaMargery Gang, Megan Othus, Roland B Walter
Blood|September 6, 2024
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in adults over 70 years oldRoland B Walter, Victoria Potter, Charles Craddock
Leukemia & Lymphoma|June 9, 2016
Incorporating measurable ('minimal') residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemiaKristen Pettit, Wendy Stock, Roland B Walter
Pageof 29